Bladder Cancer
What's New
Last Posted: Jun 19, 2024
- Enhancing bladder cancer diagnosis through transitional cell carcinoma polyp detection and segmentation: an artificial intelligence powered deep learning solution.
Mahdi-Reza Borna et al. Front Artif Intell 2024 71406806 - Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI.
Jethro C C Kwong et al. NPJ Digit Med 2024 7(1) 98 - Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study.
Rui Sun et al. Insights Imaging 2024 15(1) 21 - Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non-Muscle-Invasive Bladder Cancer.
Vikram M Narayan et al. JCO Clin Cancer Inform 2023 7e2300096 - CT-based deep learning radiomics nomogram for the prediction of pathological grade in bladder cancer: a multicenter study.
Hongzheng Song et al. Cancer Imaging 2023 23(1) 89 - Racial and sex differences in tumor genomics in urothelial carcinoma.
Yaw A Nyame et al. Urol Oncol 2023 - Real-time Detection of Bladder Cancer Using Augmented Cystoscopy with Deep Learning: a Pilot Study.
Timothy Chan Chang et al. J Endourol 2023 - Value of the application of computed tomography-based radiomics for preoperative prediction of unfavorable pathology in initial bladder cancer.
Situ Xiong et al. Cancer Med 2023 - How the Y chromosome makes some cancers more deadly for men
H Ledford, Nature, June 21, 2023 - Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy.
Charu Aggarwal et al. JAMA Netw Open 2023 6(5) e2311181 - Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
Shaoxu Wu et al. The Lancet. Oncology 2023 - A Favorable Benefit-Risk Balance Maybe Expected with the Replication-defective Adenovirus-mediated Interferon Gene Therapy for Cancer Treatment.
Albert Qin et al. Human gene therapy 2023 - Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.
Abrar Mian et al. BJUI compass 2023 4(2) 156-163 - Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis.
Nassour Anthony-Joe et al. Cancers 2023 15(2) - Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence.
Moore Nicholas S et al. Seminars in radiation oncology 2022 33(1) 70-75 - A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy.
Guo Yupeng et al. Aging 2022 14 - TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.
Pakmanesh Hamid et al. International journal of molecular sciences 2022 23(22) - Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes.
Li Lianjun et al. Aging 2022 14 - Genitourinary manifestations of Lynch syndrome in the urological practice.
Lonati Chiara et al. Asian journal of urology 2022 9(4) 443-450 - Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men.
Teleka Stanley et al. Scientific reports 2022 12(1) 18336 - Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population.
Wu Peihong et al. BioMed research international 2022 20222988159 - Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
Xu Guanghui et al. Annals of translational medicine 2022 10(16) 885 - Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
Gresser Eva et al. European urology focus 2022 - Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
Kurzrock Razelle et al. Cancers 2022 14(17) - Competitive Risk Model for Specific Mortality Prediction in Patients with Bladder Cancer: A Population-Based Cohort Study with Machine Learning.
Su Hao et al. Journal of oncology 2022 20229577904 - Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning-based image preprocessing technique.
Levy Joshua J et al. Cancer cytopathology 2022 - Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed Mohamed E et al. European urology focus 2022 - Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Pietzak Eugene J et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 - Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
Yap Timothy A et al. JAMA network open 2022 5(5) e2213070 - Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
Zeng Chenjie et al. JAMA oncology 2022 - Three-Dimensional Ultrasound Images in the Assessment of Bladder Tumor Health Monitoring under Deep Learning Algorithms.
Shao Changhua et al. Computational and mathematical methods in medicine 2022 20229170274 - Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin Immunotherapy.
Mayr Roman et al. European urology 2022 - Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients.
Ibrahim Nurul Khalida et al. Cancers 2022 14(4) - A 7-gene signature predicts the prognosis of patients with bladder cancer.
Tang Fucai et al. BMC urology 2022 22(1) 8 - Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.
O'Sullivan S et al. World journal of urology 2022 - Development and validation of Pyroptosis‑related lncRNAs prediction model for bladder cancer.
Lia Thongher et al. Bioscience reports 2022 - Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Zhipeng et al. Bioengineered 2021 - A Fact-Finding Procedure Integrating Machine Learning and AHP Technique to Predict Delayed Diagnosis of Bladder Patients with Hematuria.
Lo Chia-Lun et al. Journal of healthcare engineering 2021 20213831453 - Identification of Lymph Node Metastasis-Related Key Genes and Prognostic Risk Model in Bladder Cancer by Co-Expression Analysis.
Luo Cheng et al. Frontiers in molecular biosciences 2021 8633299 - Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer.
Kimura Koichiro et al. European radiology 2021
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: